The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study
Open accessAbstract
Introduction: Accurate and timely diagnosis of community-acquired bacterial infections in patients with systemic inflammation remains challenging both for clinician and laboratory. Combinations of markers, as opposed to single ones, may improve diagnosis and thereby survival. We therefore compared the diagnostic characteristics of novel and routinely used biomarkers of sepsis alone and in combination. Methods: This prospective cohort study included patients with systemic inflammatory response syndrome who were suspected of having community-acquired infections. It was conducted in a medical emergency department and department of infectious diseases at a university hospital. A multiplex immunoassay measuring soluble urokinase-type plasminogen activator (suPAR) and soluble triggering receptor expressed on myeloid cells (sTREM)-1 and macrophage migration inhibitory factor (MIF) was used in parallel with standard measurements of C-reactive protein (CRP), procalcitonin (PCT), and neutrophils. Two composite markers were constructed – one including a linear combination of the three best performing markers and another including all six – and the area under the receiver operating characteristic curve (AUC) was used to compare their performance and those of the individual markers. Results: A total of 151 patients were eligible for analysis. Of these, 96 had bacterial infections. The AUCs for detection of a bacterial cause of inflammation were 0.50 (95% confidence interval [CI] 0.40 to 0.60) for suPAR, 0.61 (95% CI 0.52 to 0.71) for sTREM-1, 0.63 (95% CI 0.53 to 0.72) for MIF, 0.72 (95% CI 0.63 to 0.79) for PCT, 0.74 (95% CI 0.66 to 0.81) for neutrophil count, 0.81 (95% CI 0.73 to 0.86) for CRP, 0.84 (95% CI 0.71 to 0.91) for the composite three-marker test, and 0.88 (95% CI 0.81 to 0.92) for the composite six-marker test. The AUC of the six-marker test was significantly greater than that of the single markers. Conclusion: Combining information from several markers improves diagnostic accuracy in detecting bacterial versus nonbacterial causes of inflammation. Measurements of suPAR, sTREM-1 and MIF had limited value as single markers, whereas PCT and CRP exhibited acceptable diagnostic characteristics. Trial registration: NCT 00389337
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773
Hanley, J. A., & McNeil, B. J. (1983) · Radiology · doi:10.1148/radiology.148.3.6878708 · Cited by 7,016
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
Simon, L., Gauvin, F., Amre, D. K., Saint-Louis, P., & Lacroix, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421997 · Cited by 1,787
Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M. M., Huber, P. R., Tamm, M., & Müller, B. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15591-8 · Cited by 1,096
HARBARTH, S., HOLECKOVA, K., FROIDEVAUX, C., PITTET, D., RICOU, B., GRAU, G. E., VADAS, L., PUGIN, J., & the Geneva Sepsis Network (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.3.2009052 · Cited by 898
Uzzan, B., Cohen, R., Nicolas, P., Cucherat, M., & Perret, G.-Y. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000226413.54364.36 · Cited by 738
Epidemiology of Sepsis Syndrome in 8 Academic Medical Centers
Sands, K. E. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550030074038 · Cited by 663
Soluble Triggering Receptor Expressed on Myeloid Cells and the Diagnosis of Pneumonia
Gibot, S., Cravoisy, A., Levy, B., Bene, M.-C., Faure, G., & Bollaert, P.-E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031544 · Cited by 645
Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit
Müller, B., Becker, K. L., Schächinger, H., Rickenbacher, P. R., Huber, P. R., Zimmerli, W., & Ritz, R. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004000-00011 · Cited by 628
Procalcitonin used as a marker of infection in the intensive care unit
Ugarte, H., Silva, E., Mercan, D., De Mendonca, A., & Vincent, J.-L. (1999) · Critical Care Medicine · doi:10.1097/00003246-199903000-00024 · Cited by 415
Gibot, S., Kolopp-Sarda, M.-N., Béné, M. C., Cravoisy, A., Levy, B., Faure, G. C., & Bollaert, P.-E. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-1-200407060-00009 · Cited by 407
Combining diagnostic test results to increase accuracy
Pepe, M. S. (2000) · Biostatistics · doi:10.1093/biostatistics/1.2.123 · Cited by 303
Simon et al. (2004; 39:206-17)
(2005) · Clinical Infectious Diseases · doi:10.1086/429520 · Cited by 283
Colonna, M., & Facchetti, F. (2003) · The Journal of Infectious Diseases · doi:10.1086/374754 · Cited by 281
Linear Combinations of Multiple Diagnostic Markers
Su, J. Q., & Liu, J. S. (1993) · Journal of the American Statistical Association · doi:10.1080/01621459.1993.10476417 · Cited by 278
Alberti, C., Brun-Buisson, C., Goodman, S. V., Guidici, D., Granton, J., Moreno, R., Smithies, M., Thomas, O., Artigas, A., & Le Gall, J. R. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-785oc · Cited by 262
Combining Several Screening Tests: Optimality of the Risk Score
McIntosh, M. W., & Pepe, M. S. (2002) · Biometrics · doi:10.1111/j.0006-341x.2002.00657.x · Cited by 251
Marshall, J. C., Vincent, J.-L., Fink, M. P., Cook, D. J., Rubenfeld, G., Foster, D., Fisher, C. J., Faist, E., & Reinhart, K. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000065186.67848.3a · Cited by 241
Selberg, O., Hecker, H., Martin, M., Klos, A., Bautsch, W., & Köhl, J. (2000) · Critical Care Medicine · doi:10.1097/00003246-200008000-00019 · Cited by 233
Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit
Balci, C., Sungurtekin, H., Gürses, E., Sungurtekin, U., & Kaptanoğlu, B. (2002) · Critical Care · doi:10.1186/cc1843 · Cited by 225
Predicting Bacteremia in Patients with Sepsis Syndrome
Bates, D. W., Sands, K., Miller, E., Lanken, P. N., Hibberd, P. L., Graman, P. S., Schwartz, J. S., Kahn, K., Snydman, D. R., Parsonnet, J., et al. (1997) · The Journal of Infectious Diseases · doi:10.1086/514153 · Cited by 209
Chirouze, C., Schuhmacher, H., Rabaud, C., Gil, H., Khayat, N., Estavoyer, J., May, T., & Hoen, B. (2002) · Clinical Infectious Diseases · doi:10.1086/341023 · Cited by 205
Toward Resolving the Challenges of Sepsis Diagnosis
Carrigan, S. D., Scott, G., & Tabrizian, M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.032144 · Cited by 200
Mitaka, C. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.08.018 · Cited by 195
Hausfater, P., Garric, S., Ayed, S. B., Rosenheim, M., Bernard, M., & Riou, B. (2002) · Clinical Infectious Diseases · doi:10.1086/339198 · Cited by 179
MACROPHAGE MIGRATION INHIBITORY FACTOR LEVELS CORRELATE WITH FATAL OUTCOME IN SEPSIS
Bozza, F. A., Gomes, R. N., Japiass??, A. M., Soares, M., Castro-Faria-Neto, H. C., Bozza, P. T., & Bozza, M. T. (2004) · Shock · doi:10.1097/01.shk.0000140305.01641.c8 · Cited by 174
Gaïni, S., Koldkjær, O. G., Pedersen, C., & Pedersen, S. S. (2006) · Critical Care · doi:10.1186/cc4866 · Cited by 162
Procalcitonin as a marker of bacterial infection in the emergency department: an observational study
Chan, Y., Tseng, C., Pei-Kuei, T., Chang, S.-S., Chiu, T., & Chen, J.-C. (2003) · Critical Care · doi:10.1186/cc2396 · Cited by 150
Biomarkers of sepsis: clinically useful?
Meisner, M. (2005) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000176694.92883.ce · Cited by 131
Development and Validation of a Multiplex Add-On Assay for Sepsis Biomarkers Using xMAP Technology
Kofoed, K., Schneider, U. V., Scheel, T. K. H., Andersen, O., & Eugen‐Olsen, J. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.067595 · Cited by 130
Self-citationPredicting Bacteremia at the Bedside
Jaimes, F. A., Arango, C., Ruiz, G., Cuervo, J., Botero, J., Velez, G. A., Upegui, N., & Machado, F. (2004) · Clinical Infectious Diseases · doi:10.1086/380967 · Cited by 112
Epidemiology of sepsis in Norway in 1999
Flaatten, H. K. (2004) · Critical Care · doi:10.1186/cc2867 · Cited by 102
Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections
Richeldi, L., Mariani, M., Losi, M., Maselli, F., Corbetta, L., Buonsanti, C., Colonna, M., Sinigaglia, F., Panina‐Bordignon, P., & Fabbri, L. M. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014204 · Cited by 91
Bota, D. P., Mélot, C., Ferreira, F. L., & Vincent, J. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000094223.92746.56 · Cited by 87
Prediction of Bacteremia Using TREAT, a Computerized Decision-Support System
Paul, M., Andreassen, S., Nielsen, A. D., Tacconelli, E., Almanasreh, N., Fraser, A., Yahav, D., Ram, R., Leibovici, L., & TREAT Study Group (2006) · Clinical Infectious Diseases · doi:10.1086/503034 · Cited by 78
Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections
Phua, J., Koay, E. S., Zhang, D., Tai, L. K., Boo, X. L., Lim, K., & Lim, T. K. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00005606 · Cited by 76
Murakami, Y., Akahoshi, T., Hayashi, I., Endo, H., Kawai, S., Inoue, M., Kondo, H., & Kitasato, H. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21633 · Cited by 72
Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease
Tzivras, M. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i21.3416 · Cited by 71
Jahnz‐Różyk, K. (2008) · Przewodnik Lekarza/Guide for GPs · Cited by 40
Xiong, C., McKeel, D. W., Miller, J. P., & Morris, J. C. (2004) · Medical Decision Making · doi:10.1177/0272989x04271046 · Cited by 27
(1950) · doi:10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3
Cited by
Procalcitonin as a diagnostic marker for sepsis: A systematic review and meta-analysis.
Wacker, C., Prkno, A., Brunkhorst, F. M., & Schlattmann, P. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70323-7 · Cited by 1,198
Biomarkers of sepsis: time for a reappraisal
Pierrakos, C., Velissaris, D., Bisdorff, M., Marshall, J. C., & Vincent, J.-L. (2020) · Critical Care · doi:10.1186/s13054-020-02993-5 · Cited by 713
Faix, J. D. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.764490 · Cited by 663
New Approaches to Sepsis: Molecular Diagnostics and Biomarkers
Reinhart, K., Bauer, M., Riedemann, N. C., & Hartog, C. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-12 · Cited by 533
Sepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding
Iskander, K. N., Osuchowski, M. F., Stearns-Kurosawa, D. J., Kurosawa, S., Stepien, D., Valentine, C., & Remick, D. G. (2013) · Physiological Reviews · doi:10.1152/physrev.00037.2012 · Cited by 453
Metadata
- Authors
- Kofoed, K., Andersen, O., Kronborg, G., Tvede, M., Petersen, J., Eugen-Olsen, J., & Larsen, K.
- Venue
- Critical Care
- Published
- 2007-03-16
- Volume
- 11
- Issue
- 2
- Pages
- R38-R38
- ISSN
- 1364-8535 (ISSN-L)
- OpenAlex
- W2097582396
- Cited by
- 298
- References
- 44
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.